Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17
Thorsten Maretzky(Hospital for Special Surgery), Carl Blobel(Hospital for Special Surgery)
Cited by 154
Related Papers
Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand–dependent terminal keratinocyte differentiation
|The Journal of Experimental Medicine|2012|186
Stimulation of Platelet-derived Growth Factor Receptor β (PDGFRβ) Activates ADAM17 and Promotes Metalloproteinase-dependent Cross-talk between the PDGFRβ and Epidermal Growth Factor Receptor (EGFR) Signaling Pathways
|Journal of Biological Chemistry|2010|52
FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways
|Clinical and Translational Medicine|2023|20
Identification of Molecular Determinants in iRhoms1 and 2 That Contribute to the Substrate Selectivity of Stimulated ADAM17
|International Journal of Molecular Sciences|2022|15
Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice
|Journal of Cell Science|2023|9